根据 Insight 数据库,7 月份,有 24 款新药向 NMPA 递交上市申请(含新适应症,截至 7 月 30 日),包括 12 个首次上市申请和 12 个新适应症申请。从注册分类来看,24 款药中,国产药有 15 款,进口药有 9 款。药物类型上,化药有 17 款,生物药有 7 款。本文将节选其中几款重磅抗肿瘤新药信息做介绍,仅供参阅。2025 年国内申报上市新药数量月趋势图荣昌生物“维迪西...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.